KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 2 analysts with an average price target of $34. This is a potential upside of $153.51 (3019.27%) from yesterday's end of day stock price of $1.09.

Kala Pharmaceuticals's activity chart (see below) currently has 29 price targets and 28 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.53% with an average time for these price targets to be met of 93.83 days.

Highest price target for KALA is $35, Lowest price target is $33, average price target is $34.

Most recent stock forecast was given by from HC WAINWRIGHT on 17-Sep-2025. First documented stock forecast 13-Aug-2017.

Currently out of the existing stock ratings of KALA, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Mar-2023

$35

$32.48 (1288.89%)

$12

9 months 27 days ago
(17-Sep-2025)

7/15 (46.67%)

$17.53 (100.34%)

232

Buy Since 11-Sep-2025

$33

$30.48 (1209.52%)

10 months 3 days ago
(11-Sep-2025)

0/1 (0%)

$16 (94.12%)

Buy Since 01-Jun-2020

$15

$12.48 (495.24%)

$15

1 years 3 months ago
(14-Apr-2025)

5/6 (83.33%)

$11.51 (329.80%)

307

Buy

3 years 10 months 29 days ago
(14-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

$75

$73.69 (5625.19%)

4 years 3 months 14 days ago
(29-Mar-2022)

0/2 (0%)

$2 (2.74%)

Show more analysts

Please expand the browser size to see the chart

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 93.83 days on average for the stock forecasts to be realized with a an average price target met ratio 26.53

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Francois Brisebois works at OPPENHEIMER and has 6 price targets and 4 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

David Maris with highest potential upside - $948.69

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?